These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26280899)

  • 1. Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function.
    Castellano G; Intini A; Stasi A; Divella C; Gigante M; Pontrelli P; Franzin R; Accetturo M; Zito A; Fiorentino M; Montinaro V; Lucarelli G; Ditonno P; Battaglia M; Crovace A; Staffieri F; Oortwijn B; van Amersfoort E; Pertosa G; Grandaliano G; Gesualdo L
    Am J Transplant; 2016 Jan; 16(1):325-33. PubMed ID: 26280899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction.
    Yang B; Dieudé M; Hamelin K; Hénault-Rondeau M; Patey N; Turgeon J; Lan S; Pomerleau L; Quesnel M; Peng J; Tremblay J; Shi Y; Chan JS; Hébert MJ; Cardinal H
    Am J Transplant; 2016 Dec; 16(12):3416-3429. PubMed ID: 27172087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic acute kidney injury and klotho in renal transplantation.
    Panah F; Ghorbanihaghjo A; Argani H; Asadi Zarmehri M; Nazari Soltan Ahmad S
    Clin Biochem; 2018 May; 55():3-8. PubMed ID: 29608890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Complement Pathways During Cold Ischemia and Reperfusion Prevents Delayed Graft Function.
    Yu ZX; Qi S; Lasaro MA; Bouchard K; Dow C; Moore K; Wu Z; Barama A; Xu J; Johnson K; Marozsan AJ; Wang Y
    Am J Transplant; 2016 Sep; 16(9):2589-97. PubMed ID: 27003920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients.
    Jordan SC; Choi J; Aubert O; Haas M; Loupy A; Huang E; Peng A; Kim I; Louie S; Ammerman N; Najjar R; Puliyanda D; Vo A
    Am J Transplant; 2018 Dec; 18(12):2955-2964. PubMed ID: 29637714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischaemia-reperfusion injury: a major protagonist in kidney transplantation.
    Ponticelli C
    Nephrol Dial Transplant; 2014 Jun; 29(6):1134-40. PubMed ID: 24335382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival.
    Lau A; Wang S; Jiang J; Haig A; Pavlosky A; Linkermann A; Zhang ZX; Jevnikar AM
    Am J Transplant; 2013 Nov; 13(11):2805-18. PubMed ID: 24103001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenon treatment protects against cold ischemia associated delayed graft function and prolongs graft survival in rats.
    Zhao H; Watts HR; Chong M; Huang H; Tralau-Stewart C; Maxwell PH; Maze M; George AJ; Ma D
    Am J Transplant; 2013 Aug; 13(8):2006-18. PubMed ID: 23710625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted donor complement blockade after brain death prevents delayed graft function in a nonhuman primate model of kidney transplantation.
    Danobeitia JS; Zens TJ; Chlebeck PJ; Zitur LJ; Reyes JA; Eerhart MJ; Coonen J; Capuano S; D'Alessandro AM; Torrealba JR; Burguete D; Brunner K; Van Amersfoort E; Ponstein Y; Van Kooten C; Jankowska-Gan E; Burlingham W; Sullivan J; Djamali A; Pozniak M; Yankol Y; Fernandez LA
    Am J Transplant; 2020 Jun; 20(6):1513-1526. PubMed ID: 31922336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of renal ischemia reperfusion injury subtypes and predictive strategies for delayed graft function and graft survival based on neutrophil extracellular trap-related genes.
    Wu J; Zhang F; Zheng X; Zhang J; Cao P; Sun Z; Wang W
    Front Immunol; 2022; 13():1047367. PubMed ID: 36532016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective postreperfusion metabolic recovery directly associates with incident delayed graft function.
    Wijermars LG; Schaapherder AF; de Vries DK; Verschuren L; Wüst RC; Kostidis S; Mayboroda OA; Prins F; Ringers J; Bierau J; Bakker JA; Kooistra T; Lindeman JH
    Kidney Int; 2016 Jul; 90(1):181-91. PubMed ID: 27188504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nox2 is a mediator of ischemia reperfusion injury.
    Karim AS; Reese SR; Wilson NA; Jacobson LM; Zhong W; Djamali A
    Am J Transplant; 2015 Nov; 15(11):2888-99. PubMed ID: 26104383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrin curcumin formulation improves outcome in a preclinical pig model of marginal kidney transplantation.
    Thuillier R; Allain G; Giraud S; Saintyves T; Delpech PO; Couturier P; Billault C; Marchand E; Vaahtera L; Parkkinen J; Hauet T
    Am J Transplant; 2014 May; 14(5):1073-83. PubMed ID: 24618351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement Alternative Pathway Deficiency in Recipients Protects Kidney Allograft From Ischemia/Reperfusion Injury and Alloreactive T Cell Response.
    Casiraghi F; Azzollini N; Todeschini M; Fiori S; Cavinato RA; Cassis P; Solini S; Pezzuto F; Mister M; Thurman JM; Benigni A; Remuzzi G; Noris M
    Am J Transplant; 2017 Sep; 17(9):2312-2325. PubMed ID: 28276660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemia reperfusion injury in kidney transplantation: A case report.
    Philipponnet C; Aniort J; Garrouste C; Kemeny JL; Heng AE
    Medicine (Baltimore); 2018 Dec; 97(52):e13650. PubMed ID: 30593134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial.
    Kassimatis T; Qasem A; Douiri A; Ryan EG; Rebollo-Mesa I; Nichols LL; Greenlaw R; Olsburgh J; Smith RA; Sacks SH; Drage M
    Trials; 2017 Jun; 18(1):255. PubMed ID: 28587616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor Urinary C5a Levels Independently Correlate With Posttransplant Delayed Graft Function.
    Schröppel B; Heeger PS; Thiessen-Philbrook H; Hall IE; Doshi MD; Weng FL; Reese PP; Parikh CR
    Transplantation; 2019 Jan; 103(1):e29-e35. PubMed ID: 30451738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte depletion and risk of acute rejection in renal transplant recipients at increased risk for delayed graft function.
    Ravindra KV; Sanoff S; Vikraman D; Zaaroura A; Nanavati A; Sudan D; Irish W
    Am J Transplant; 2019 Mar; 19(3):781-789. PubMed ID: 30171800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.
    Hu C; Li L; Ding P; Li L; Ge X; Zheng L; Wang X; Wang J; Zhang W; Wang N; Gu H; Zhong F; Xu M; Rong R; Zhu T; Hu W
    J Immunol; 2018 Dec; 201(12):3717-3730. PubMed ID: 30429287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Klotho Reduces Necroptosis by Targeting Oxidative Stress Involved in Renal Ischemic-Reperfusion Injury.
    Qian Y; Guo X; Che L; Guan X; Wu B; Lu R; Zhu M; Pang H; Yan Y; Ni Z; Gu L
    Cell Physiol Biochem; 2018; 45(6):2268-2282. PubMed ID: 29550818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.